News

Scipher Medicine, a precision immunology company matching patients with the most effective therapy, in collaboration with Northeastern University; Brigham and Women’s Hospital, Harvard…
Read More...

Indivior PLC, announced that it is extending its leadership position in substance use disorder ("SUD") treatment by expanding into the under treated cannabis-related disorders,…
Read More...

Icosavax, Inc. announced the first subjects have been dosed with IVX-411, a virus-like particle (VLP) displaying the SARS-CoV-2 receptor-binding domain (RBD), in a Phase 1/2 clinical…
Read More...

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research,…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in…
Read More...

argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced it will regain worldwide rights to its…
Read More...

Samyang Holdings signed an MOU to co-develop a vaccine for COVID-19 with “mCureX (CEO: Hong Sun-woo),” a subsidiary of a “OliX Pharmaceuticals (CEO: Lee Dong-ki),” a pharmaceutical…
Read More...

Biogen and Eisai, Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s…
Read More...

Ascletis Pharma Inc. announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to…
Read More...

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...

Merck known as MSD outside the United States and Canada, announced it has completed the spinoff of Organon & Co. (Organon). “Today marks a significant milestone for both Merck…
Read More...

Bayer announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this acquisition, Bayer will obtain exclusive rights…
Read More...

BioCryst Pharmaceuticals, Inc. announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the…
Read More...

Moderna, Inc. announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a…
Read More...

MorphoSys AG and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation for $34.00 per share in…
Read More...

Centivax Inc. announced that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's…
Read More...

Primordial Genetics a synthetic biology company developing enzymatic production systems for nucleic acids,  announced granting Arcturus Therapeutics Holdings Inc. a clinical-stage…
Read More...

GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that it has entered into an agreement with Thermo Fisher Scientific (NYSE: TMO)…
Read More...